2923 Stock Overview
Develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Zhuhai Rundu Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.25 |
| 52 Week High | CN¥14.06 |
| 52 Week Low | CN¥6.81 |
| Beta | 0.37 |
| 11 Month Change | -15.91% |
| 3 Month Change | -9.40% |
| 1 Year Change | -29.39% |
| 33 Year Change | -29.35% |
| 5 Year Change | -12.55% |
| Change since IPO | 23.74% |
Recent News & Updates
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20
May 29
There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings
May 05Recent updates
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20
May 29There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings
May 05There's Reason For Concern Over Zhuhai Rundu Pharmaceutical Co., Ltd.'s (SZSE:002923) Massive 32% Price Jump
Mar 05Shareholder Returns
| 2923 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.9% | -5.4% | -4.7% |
| 1Y | -29.4% | -15.1% | -17.5% |
Return vs Industry: 002923 underperformed the CN Pharmaceuticals industry which returned -13.7% over the past year.
Return vs Market: 002923 underperformed the CN Market which returned -16% over the past year.
Price Volatility
| 2923 volatility | |
|---|---|
| 2923 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 002923 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002923's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,945 | Jie Liu | www.rdpharma.cn |
Zhuhai Rundu Pharmaceutical Co., Ltd. develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide. It offers APIs, intermediates, FDF, and pellets. The company was founded in 1997 and is headquartered in Zhuhai, China.
Zhuhai Rundu Pharmaceutical Co., Ltd. Fundamentals Summary
| 2923 fundamental statistics | |
|---|---|
| Market cap | CN¥3.10b |
| Earnings (TTM) | CN¥55.52m |
| Revenue (TTM) | CN¥1.24b |
55.8x
P/E Ratio2.5x
P/S RatioIs 2923 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2923 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.24b |
| Cost of Revenue | CN¥654.50m |
| Gross Profit | CN¥584.12m |
| Other Expenses | CN¥528.60m |
| Earnings | CN¥55.52m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.17 |
| Gross Margin | 47.16% |
| Net Profit Margin | 4.48% |
| Debt/Equity Ratio | 48.6% |
How did 2923 perform over the long term?
See historical performance and comparison